Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Whitehawk Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | Restricted Stock Units | 776K | $1.86M | $2.40 | Apr 1, 2025 | Direct |
Aadi Bioscience, Inc. | CHIEF EXECUTIVE OFFICER, Director | Common Stock | 33.4K | $78.6K | $2.35 | Mar 3, 2025 | Direct |
Whitehawk Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | Stock Option (right to buy) | 776K | Apr 1, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
WHWK | Whitehawk Therapeutics, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | CHIEF EXECUTIVE OFFICER, Director |
AADI | Aadi Bioscience, Inc. | Mar 1, 2025 | 3 | -$13.4K | 4 | Mar 3, 2025 | CHIEF EXECUTIVE OFFICER, Director |
AADI | Aadi Bioscience, Inc. | Oct 2, 2024 | 3 | -$18.8K | 4 | Oct 3, 2024 | CHIEF EXECUTIVE OFFICER, Director |
AADI | Aadi Bioscience, Inc. | Mar 1, 2024 | 3 | $0 | 4 | Mar 4, 2024 | CHIEF EXECUTIVE OFFICER, Director |
AADI | Aadi Bioscience, Inc. | Oct 2, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Chief Executive Officer, Director |
AADI | Aadi Bioscience, Inc. | Oct 2, 2023 | 0 | $0 | 3 | Oct 3, 2023 | Chief Executive Officer, Director |